Cytokine Profiles in Children With Obstructive Sleep Apnea
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00456573 |
Recruitment Status
: Unknown
Verified June 2008 by University of Chicago.
Recruitment status was: Recruiting
First Posted
: April 5, 2007
Last Update Posted
: June 3, 2008
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Obstructive Sleep Apnea Syndrome | Procedure: tonsillectomy | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 40 participants |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Official Title: | Local and Systemic Cytokine Profiles in Children With Obstructive Sleep Apnea and Controls |
Study Start Date : | April 2006 |
Estimated Primary Completion Date : | September 2008 |
Estimated Study Completion Date : | December 2008 |

-
Procedure: tonsillectomy
- levels of cytokines released from PBMCs of OAS subjects and controls [ Time Frame: just prior to surgery ]
- cytokine level comparison between PBMCs and tonsillar lymphocytes within OAS groups [ Time Frame: at time of surgery ]

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Months to 12 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- OSA documented by polysomnography and clinical symptoms.
- Patients with no symptoms of OSA and negative sleep questionnaire.
Exclusion Criteria:
- Significant systemic disease except mild asthma

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00456573
Contact: Fuad M Baroody, MD | 773-702-4790 | fbaroody@surgery.bsd.uchicago.edu |
United States, Illinois | |
University of Chicago | Recruiting |
Chicago, Illinois, United States, 60637 | |
Principal Investigator: Fuad M Baaroody, MD |
Principal Investigator: | Fuad M Baroody, MD | University of Chicago |
Responsible Party: | Fuad M. Baroody, MD, University ofChicago |
ClinicalTrials.gov Identifier: | NCT00456573 History of Changes |
Other Study ID Numbers: |
002 (14437B) |
First Posted: | April 5, 2007 Key Record Dates |
Last Update Posted: | June 3, 2008 |
Last Verified: | June 2008 |
Keywords provided by University of Chicago:
Pediatric Obstructive sleep apnea syndrome |
Additional relevant MeSH terms:
Apnea Sleep Apnea Syndromes Sleep Apnea, Obstructive Respiration Disorders Respiratory Tract Diseases Signs and Symptoms, Respiratory |
Signs and Symptoms Sleep Disorders, Intrinsic Dyssomnias Sleep Wake Disorders Nervous System Diseases |